News

Regeneron to buy bankrupt 23andMe, vows ethical use of customer DNA data
Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...
Fate of 23andMe genetic data still not settled amid bankruptcy fight
Me is proposing to reopen its bankruptcy auction to entertain a final offer from a nonprofit operated by its co-founder, ...
Regeneron is trying to buy 23andMe – and by extension, your DNA information | Opinion
Me’s sale to Regeneron is not yet a done deal. The privacy ombudsman is scheduled to report on the privacy aspects of the ...
STAT6dOpinion
I worked at 23andMe during its collapse. Here’s what the next consumer-genomics giant needs to understand
In trying to lead before the system could follow, 23andMe outpaced the very guardrails that might have legitimized it”: A ...
23andMe sold out and sold your genetic info, no consent necessary
We’ve entered an era where biometric identity is currency. Regeneron just cornered a market without asking the public, the ...
23andMe’s Former CEO Pushes Purchase Price Nearly $50 Million Higher
Me has a path to a higher purchase price than the $256 million offered by biotech giant Regeneron after the genetic-testing ...
The Company Buying 23andMe Is a Pharmaceutical Giant. Here's How Investors Can Benefit From the Move.
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
23andMe Judge Questions Limits for New Auction for Bankrupt Firm
The judge overseeing the bankruptcy of 23andMe questioned the limits proposed for a second auction that is designed to push ...